NCT05004103

Brief Summary

The skin microbiome diversity in female healthy volunteers will be studied along with cosmetic products application in 1 month period. This study is also aimed to investigate the efficacy of cosmetic products on skin rejuvenation. .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 29, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 8, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 13, 2021

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2021

Completed
Last Updated

August 13, 2021

Status Verified

August 1, 2021

Enrollment Period

2 months

First QC Date

July 8, 2021

Last Update Submit

August 12, 2021

Conditions

Keywords

Skin MicrobiomeFacial Skin MicrobiomeMIcrobiome diversity

Outcome Measures

Primary Outcomes (8)

  • Microbiome diversity index

    The amount and diversity of microbiota will be observed on facial skin before and after product application

    28 days

  • Facial skin elasticity

    The ratio between pliability/firmness and expressed in mm. The result before and after product application will be observed by cutometer.

    28 days

  • Sebum unit of facial skin

    Sebumeter unit (mcg/cm2) of facial skin before and after product application will be observed using sebumeter. This sebumeter unit reflects the concentration of sebum on skin per observed area.

    28 days

  • Capacity of corneometer unit

    Corneometer unit reflects the moist index of skin. The corneometer unit observed by Corneometer, before and after product application.

    28 days

  • Skin color intensity

    The skin color expressed in colorimeter index value. The observation is conducted before and after product application

    28 dyas

  • Transepidermal Waterloss (g/h/m2)

    The hydration of skin is observed by Tewameter. The observation is conducted before and after product application

    28 days

  • pH of facial skin

    The pH of facial skin is observed using skin-pH-meter. Observation is conducted before and after product application

    28 days

  • The skin color related to the Minimal Erythema Dosage (MED)

    The skin color (MED) is observed using Mexameter and is conducted before and after product application

    28 Days

Study Arms (1)

Skin microbiome evaluation

EXPERIMENTAL

Female healthy volunteers applied cosmetic products (cleanser and moisturizer cream), the diversity of skin microbiome will be examined before and after using the products

Other: Cosmetic products application

Interventions

Female healthy volunteers applied cosmetic products (cleanser and moisturizer) in the morning and afternoon for 1 month. Seven days wash out period will be conducted prior study starts. The evaluation will be conducted before, two weeks after treatment starts, and at the end of the study.

Skin microbiome evaluation

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsHealthy females
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • female 18-35 years old
  • signed the informed consent

You may not qualify if:

  • infected by COVID-19
  • females with skin diseases on face and neck such as atopic dermatitis, skin allergy, acne with moderate and severe degree, seborrheic dermatitis, malignancy
  • females with ongoing skin treatments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Research Supporting Unit

Jakarta Pusat, DKI Jakarta, 10430, Indonesia

Location

Related Publications (6)

  • Collins-Fulea C, Klima K, Wegienka GR. Prevalence of low vitamin D levels in an urban midwestern obstetric practice. J Midwifery Womens Health. 2012 Sep-Oct;57(5):439-44. doi: 10.1111/j.1542-2011.2012.00167.x.

    PMID: 22954074BACKGROUND
  • Vijay A, Gupta S, Rawat S, Jain SK. A Rare Case of Coinfection with White Piedra and Pediculosis Capitis. Indian Dermatol Online J. 2017 Jul-Aug;8(4):279-280. doi: 10.4103/idoj.IDOJ_353_16. No abstract available.

    PMID: 28761849BACKGROUND
  • Wallen-Russell, C. The Role of Every-Day Cosmetics in Altering the Skin Microbiome: A Study Using Biodiversity. Cosmetics 2019, 6, 2. https://doi.org/10.3390/cosmetics6010002

    BACKGROUND
  • Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018 Mar;16(3):143-155. doi: 10.1038/nrmicro.2017.157. Epub 2018 Jan 15.

  • Ogai K, Nagase S, Mukai K, Iuchi T, Mori Y, Matsue M, Sugitani K, Sugama J, Okamoto S. A Comparison of Techniques for Collecting Skin Microbiome Samples: Swabbing Versus Tape-Stripping. Front Microbiol. 2018 Oct 2;9:2362. doi: 10.3389/fmicb.2018.02362. eCollection 2018.

  • Lee HJ, Jeong SE, Lee S, Kim S, Han H, Jeon CO. Effects of cosmetics on the skin microbiome of facial cheeks with different hydration levels. Microbiologyopen. 2018 Apr;7(2):e00557. doi: 10.1002/mbo3.557. Epub 2017 Nov 29.

Study Officials

  • Frans Suyatna, Prof, PhD

    Clinical Research Supporting Unit, Faculty of Medicine, University of Indonesia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Pre-post study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Pharmacology Professor

Study Record Dates

First Submitted

July 8, 2021

First Posted

August 13, 2021

Study Start

March 29, 2021

Primary Completion

May 31, 2021

Study Completion

August 20, 2021

Last Updated

August 13, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations